Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Exeporfinium chloride demonstrates safety, tolerability and efficacy in U.S. clinical trial

Sep. 6, 2016

Dynavax provides update on recent dialogue with FDA regarding Heplisav-B BLA

Sep. 5, 2016

GSK initiates phase IIa trial of shigella vaccine in Kenya

Sep. 5, 2016

University of Dundee, GlaxoSmithKline develop novel compound for leishmaniasis

Sep. 2, 2016

SK Chemicals launches SKYCellflu Quadrivalent influenza vaccine in South Korea

Sep. 1, 2016

Arbutus Biopharma terminates exclusive license agreement with Kuros Biosciences

Aug. 31, 2016

GlaxoSmithKline tests novel antimalarial quinazolindiones

Aug. 31, 2016

NCATS identifies compounds with potential through Zika screening program

Aug. 30, 2016

Spotlight Innovation enters sponsored research agreement with FSU to treat Zika infection

Aug. 29, 2016

Ginkgo Pharmaceutical describes novel nucleoside derivatives

Aug. 29, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...